Credivalores obtains new funding sources for COP$400 billion (about US$90 million)
Bogotá, September 14th, 2022
These new funding sources include two new financing structures for payroll loans through a Private Equity Fund and SPVs and a sale of future cash flows of non-performing loans.
Credivalores announces the payment of USD$168 million on their bond maturities
Bogotá, July 27th, 2022
Credivalores paid this July 27th its 144 A- Regulation S bond. This last payment corresponds to the remainder of the outstanding bonds initially issued in 2017 and 2018 for a total of USD$325 million.
Fitch Affirms Credivalores' 'B';Removes Rating WatchNegative; Outlook Negative
Bogotá, June 1, 2022
Fitch Ratings - New York - 01 Jun 2022: Fitch Ratings has removed the Rating WatchNegative (RWN) and affirmed Credivalores-Crediservicios S.A.'s
Credivalores successfully issued a new US$20 million note under the ECP Program
Bogotá, June 9, 2020
Despite of the difficulties that most consumer lending companies in Latin America face today, Credivalores was able to close this transaction maintaining the same coupon rate from issuances in 2018 and 2019
Credivalores successfully reopens it international bond for US$75 million in the capital markets
Bogota, Feb 13, 2018
The successful results from this reopening after seven months of the original issuance of the international bond, confirm the great interests from international investors in Credivalores’ business model and leadership position in the Colombian consumer lending and payroll loan segment of the population not properly served by traditional commercial banks
Credivalores successfully issues US$250 million in the international capital markets
Bogota, July 23rd, 2017
Credivalores-Crediservicios S.A. (“Credivalores”), the leading non-banking financial institution in Colombia with over 14 years of experience, announces that on July 27th, 2017, the Company successfully accessed the international bond markets, pricing its debut 144A / Reg S transaction via a US$250 million senior unsecured bond with a five year tenor. The issuer and the notes are rated B+ (stable) by Standard & Poor’s and by Fitch Ratings.